PAZ Pharma Zen

[percy]

The capital raised together with retained earnings will see production triple over the next couple of years.
Strengthens the balance sheet,and means PAZ can get on with all their capital projects.
Cibus Capital have spent a lot of time [about a year] doing audits,not just financial.They have access to expertise and good world wide contacts.
Exciting being in the right company, in the right sector, at the right time.

[whatsup]

The capital raised together with retained earnings will see production triple over the next couple of years.
Strengthens the balance sheet,and means PAZ can get on with all their capital projects.
Cibus Capital have spent a lot of time [about a year] doing audits,not just financial.They have access to expertise and good world wide contacts.
Exciting being in the right company, in the right sector, at the right time.

Could there be an outside chance that we could be offered a SPP.

I asked at the virtual meeting of the chance of a C R , answer was not at present, I guess that was then and this is NOW !! DAMM !.

[percy]

Could there be an outside chance that we could be offered a SPP.

I asked at the virtual meeting of the chance of a C R , answer was not at present, I guess that was then and this is NOW !! DAMM !.

I very much doubt it.
This capital injection,together with retained earnings, will fund PAZ's capital program,which I take will be approx $25mil.
Freight inwards and outwards remains a world wide issue.
Had PAZ not raised the capital they would have had to take on a lot of debt.With freight issues, such as 12 containers for one imported freeze drier, and other factory equipment being held up, it would have possibly put them under financial pressure.
I think they did look at either raising capital from shareholders,debt or bringing in a supplier.However they did see a lot of benefits having Cibus onboard.
As we know the directors own nearly 50% of the company,so have the owner's eye.

[macduffy]

Yes, it's a shame that shareholders aren't participating in this capital raising but at least there's the comfort of having a big - and presumably well-informed - new shareholder. My biggest concern has been, and remains, access to an adequate, increased quantity of raw materials.

[percy]

https://www.stuff.co.nz/business/123...-new-factories

[macduffy]

Thanks, percy. It seems the supply of raw materials is under control.

[percy]

Thanks, percy. It seems the supply of raw materials is under control.

GMP (Good Manufacturing Practice) certification – Approved to manufacture an
“Active Pharmaceutical Ingredient” under a “Licence to Manufacture Medicines”
authorised by Medsafe (New Zealand Medicines and Medical Devices
Safety Authority.
The above tells us that PAZ no longer produce just "commodity" products,but up to and including" pharmaceutical ingredient" grade.
The closer you get to pharmaceutical ingredient grade the higher your margin, and the price you sell your product gets.
A few years ago there was a shortage of mussels.The price of them went sky high.I asked how this affected PAZ."No problem,as we make the most out of each mussel, if need be we can pay top price for our supply."
I guess it goes for all or most of the raw materials PAZ use.Just a pity they are not doing anything [as far as I know ] with Central Otago Cherries.

[petty]

I understand some commentary here regarding share dilution and being sidelined as a retailed investor. It’s a bummer. With that in mind, I hold the view that this was not a ‘capital raise’ in its pure form. This was about on boarding ‘smart money’. How smart or strategic this money will be is going to be interesting but I thinks it’s a great move. The reason I don’t think it’s purely about capital is I think with the price of money and capital available domestically I think they could have raised that amount easily at .50c or at least mid 40’s from the domestic market.

instead I think this is about ‘networks’ and ‘’know how’ within the European market.

Psyched about the update.

[Beat the Bank]

I understand some commentary here regarding share dilution and being sidelined as a retailed investor. It’s a bummer. With that in mind, I hold the view that this was not a ‘capital raise’ in its pure form. This was about on boarding ‘smart money’. How smart or strategic this money will be is going to be interesting but I thinks it’s a great move. The reason I don’t think it’s purely about capital is I think with the price of money and capital available domestically I think they could have raised that amount easily at .50c or at least mid 40’s from the domestic market.

instead I think this is about ‘networks’ and ‘’know how’ within the European market.

Psyched about the update.

I hope you are right there. In the meantime, pop down to the Chemist Warehouse and pick up some AiORA at $6 off and buy one get one free.

[Tony Two Gloves]

I understand some commentary here regarding share dilution and being sidelined as a retailed investor. It’s a bummer. With that in mind, I hold the view that this was not a ‘capital raise’ in its pure form. This was about on boarding ‘smart money’. How smart or strategic this money will be is going to be interesting but I thinks it’s a great move. The reason I don’t think it’s purely about capital is I think with the price of money and capital available domestically I think they could have raised that amount easily at .50c or at least mid 40’s from the domestic market.

instead I think this is about ‘networks’ and ‘’know how’ within the European market.

Psyched about the update.

I tend to agree with this, they could have quite easily raised this amount from existing shareholders at $0.50 a share or in my opinion quite easily transitioned to the main board and raised more capital at the same time. From memory they have mentioned partnering with the right people in the past and getting someone like this on board I believe is extremely smart and will eventually be a great benefit to all. Saying that would have filled my boots to buy more at $0.40